Background {#S0001}
==========

Diabetes mellitus has emerged asa global life-threatening metabolic disorder characterized by hyperglycemia due to impaired insulin secretion or action.[@CIT0001],[@CIT0004] Insulin resistance causes the development of life-threatening complications including hypertension, dyslipidemia, and atherosclerosis.[@CIT0005] The prevalence and burden of diabetes mellitus is very high in the world. In 2017, 425 million people live with diabetes and this number will increase to 629 million in 2045. Among all types of diabetes mellitus, type 2 diabetes contributes greater than 90%.[@CIT0006] Glucose homeostasis is maintained through phosphatidylinositol 3-kinase (PI3K), adenosine monophosphate kinase (AMPK), and peroxisome proliferator-activated receptor-γ (PPAR-γ) signal transduction pathways. Phytochemicals play a vital role in glycemic control through modulating of PI3K, AMPK, and PPAR-γ signal transduction pathways.[@CIT0007],[@CIT0009]

Nature has gifted a variety of vital phytochemicals having a potential effect against diabetes mellitus. A modern antidiabetic drug (metformin) has been isolated from medicinal plants.[@CIT0010],[@CIT0011] In recent years, many plant species have shown promising effects against diabetes mellitus. For instance, Catechol glycoside esters, isolated from the leaves of *Dodecadenia grandiflora* and protodioscin isolated from the seed of fenugreek showed a very good effects on blood glucose level.[@CIT0009],[@CIT0012] *Moringa stenopetala* and *Aloe Vera* offer useful and promising evidence for the development of plant-based antidiabetic drugs.[@CIT0013],[@CIT0015]

*Datura stramonium* is belonging to the genus *Datura* and family Solanaceae. Even though *D. stramonium* originates in America, nowadays the plant is widely distributed throughout the world, including Ethiopia. The plant is a widespread annual plant and grows to 1.2 m high. The root of the plant is long, thick, fibrous, white, and the stem is stout, erect, leafy, smooth, and pale yellow-green ([Figure 1](#F0001){ref-type="fig"}).[@CIT0016],[@CIT0017]Figure 1Picture of *Datura stramonium.*

The seeds of *Datura stramonium* contain amino acids (alanine, glutamate, phenylalanine, and tyrosine) along with numerous other phytochemicals, for instance, alkaloidal drugs including scopolamine, atropine, and hyoscyamine.[@CIT0018],[@CIT0021]

Various studies showed that *Datura stramonium* endowed antiepileptic, anti-obesity, anti-microbial, anti-viral, anticholinergic, and bronchodilator activities.[@CIT0018],[@CIT0020],[@CIT0022],[@CIT0023] Hydromethanolic, the root extract, endowed significant antidiabetic and antidyslipidemic activity in mice.[@CIT0024] In another study, methanolic, the seed extract of *D. stramonium*, revealed higher (94.56%) α-amylase inhibitory activity, despite a lack of in vivo investigation.[@CIT0025] The plant has been used as a remedy for the treatment of diabetes mellitus and others diseases.[@CIT0026] These pertain to determine the antidiabetic potential of hydromethanolic seed extract of *Datura stramonium* in STZ-induced type 1 diabetic model.

Methods {#S0002}
=======

Drugs, Chemicals, and Instruments {#S0002-S2001}
---------------------------------

Streptozotocin (Sigma Aldrich, Germany), glibenclamide (Julphar Pharmaceuticals), 80% methanol, FeCl~3~ (MA, USA), NaOH (India), HCl (Suppertek Chemical), 40% glucose solution (Shandong, China), Lyophilizer, i-QARE DS-W^®^ blood glucose meter, and test strips (Alliance International, New Taipei City, Taiwan), scissors, mask, animal cages, insulin syringe with needle, oven, and desiccators were used in this experimental study.

Plant Material Collection {#S0002-S2002}
-------------------------

The seeds of *D. stramonium* were collected from Wollo in October 2019. Plant identification was carried out and the specimen of the plant material was deposited in Wollo University with the specimen voucher number GG-004/2019.

Preparation of Plant Extract {#S0002-S2003}
----------------------------

The seeds were washed with distilled water, dried under shade, and then dried seeds were reduced into coarse powder by using an electric mill. The coarse powder of the seed (200 g) was maceration in hydromethanol. After 72 hours, filtration was carried out by using white cotton gauze and Whatman filter paper No.1. The marc was re-macerated twice in hydromethanol for 72 hours and then filtered again. The filtrates were collected and concentrated using a rotary evaporator under reduced pressure at 40°C. Methanol was evaporated in an oven at 40°C and the water was removed by using a lyophilizer. The dried seed extract was kept in a clean and dry vial, then stored in a desiccator until used for the experiment.

Experimental Animals {#S0002-S2004}
--------------------

The mice were obtained from Wollo University pharmacology department and were handled in a 12 hour light--dark cycle with pellet diet and water *ad libitum*. Healthy male Swiss albino mice with body weight of 20--35 g and age of 8--12 weeks were used in the experimental study and healthy female mice with the same weight and age were used for an acute oral toxicity study. This study was carried out based on the guide for the care and use of laboratory animals.[@CIT0027]

Phytochemical Analysis of Seed Extract of *D. stramonium* {#S0002-S2005}
---------------------------------------------------------

Qualitative preliminary screening was carried out in the seed extract to determine the presence of flavonoids, alkaloids, tannins, steroids, phenols, saponins, glycosides, and anthraquinones according to the standard methods.[@CIT0028],[@CIT0029]

### Test for Flavonoids (Lead Acetate Test) {#S0002-S2005-S3001}

Ten milligrams of the seed extract was measured and a few drops of 10% lead acetate solution was added. The appearance of yellow color precipitate indicates the presence of flavonoids.

### Test for Alkaloids (Wagner's Test) {#S0002-S2005-S3002}

Ten milligrams of hydromethanolic seed extract was dissolved in distilled water. Three drops of Wagner's reagent were then added to the mixture; formation of a reddish brown color indicates a positive result for the presence of terpenoids.

### Test for Tannins (Lead Acetate Test) {#S0002-S2005-S3003}

About 0.05 g of seed extract was dissolved in 1 mL distilled water and then 0.5 mL of 1% lead acetate solution was added. The appearance of yellowish color precipitate on the mixture confirmed a positive result for the presence of tannins.

### Test for Phenols (Ferric Chloride Test) {#S0002-S2005-S3004}

Ten milligrams of seed extract was dissolved in 1 mL distilled water. Then, 0.5 mL of 5% ferric chloride was added and the formation of black color indicated the presence of phenols.

### Test for Steroids {#S0002-S2005-S3005}

About 0.5 g seed extract was dissolved in 0.5 mL dichloromethane to produce a dilute solution, and 0.5 mL of acetic anhydride was added, followed by three drops of concentrated sulphuric acid. The appearance of a blue-green color on the mixture confirmed the presence of steroids.

### Test for Saponins (Foam Test) {#S0002-S2005-S3006}

About 0.3 g of the seed extract was dissolved in 20 mL of distilled water. The formation of 3 cm persistent foam on vigorous shaking observed for 30 minutes indicates a positive result for the presence of saponins.

### Test for Glycosides (Glycoside Test) {#S0002-S2005-S3007}

About 1 g of seed extract was dissolved in 1 mL of distilled water and then three drops of 20% sodium hydroxide solution was added. The formation of yellowish color confirmed a positive result for the presence of glycosides.

### Test for Anthraquinones (Borntragers Test) {#S0002-S2005-S3008}

About 0.5 g seed extract was taken into a dry test tube and 5 mL of chloroform was added and shaken for 5 minutes. The extract was filtered and the filtrate was shaken with an equal volume of 10% ammonia solution. A pink violet in the lower layer indicates the presence of anthraquinones.

Toxicity Study {#S0002-S2006}
--------------

An acute oral toxicity study was conducted according to OECD guideline 425.[@CIT0030] One healthy female mouse was fasted for 3--4 hours and then body weight was measured. The seed extract at the dose of 2,000 mg/kg was given orally to the mouse and strictly observed for 24 hours of physical and behavioral changes, giving special attention to the first 4 hours. Based on the result, another four mice were fasted for 3--4 hours and fasted body weight was measured. The seed extract at the dose of 2,000 mg/kg was given to each mouse and they were observed in the same manner to determine physical and behavioral changes of mice. Follow-up was continued for 2 weeks for any physical and behavioral changes of the mice before initiation of the experiment.

In vitro Antioxidant Activity of Hydromethanolic Seed Extract of *D. stramonium* {#S0002-S2007}
--------------------------------------------------------------------------------

Antioxidant activity of the seed extract was evaluated in 2, 2-diphenyl-1-picrylhydrazyl method.[@CIT0031] Diphenyl-1-picrylhydrazine ( DPPH) solution (3.9 mL) (4 mg DPPH/100 mL methanol) was mixed with a 0.1 mL methanolic solution (5--80 mg/mL) of seed extract and incubated in the dark for half an hour. Ascorbic acid was used as a standard antioxidant. After half an hour, the absorbance of the mixture and the control were read at 517 nm by using a UV spectrophotometer. The test was done in triplicate and the percentage of inhibition was calculated as: $$\documentclass[12pt]{minimal}
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where AbsControl was the absorbance without sample, AbsSamples was the absorbance of the sample latex or ascorbic acid.

Induction of Diabetes {#S0002-S2008}
---------------------

Streptozocin (STZ) was dissolved in 0.1 M fresh cold citrate buffer (pH 4.5). Type 1 diabetes was induced by injection (i.p.) of Streptozocin solution at the single dose of 150 mg/kg.[@CIT0032],[@CIT0034] After 30 minutes, pallet diet was allowed to the mice and after 6 hours of STZ injection, glucose solution (5%) was given to each mouse for 1 day to prevent hypoglycemic shock. After 72 hours of STZ injection, a fasting blood glucose level in each mouse \>200 mg/dL was considered diabetic and used in the study.[@CIT0035],[@CIT0037]

Evaluation of Hypoglycemic Effect of the Seed Extract in Normoglycemic Mice {#S0002-S2009}
---------------------------------------------------------------------------

Normoglycemic mice were fasted overnight (16 hours) and randomly assigned into five groups (n=6). Group I (negative control) was treated with 10 mL/kg distilled water and Group II (positive control) was treated with 5 mg/kg glibenclamide, Groups III, IV, and V were treated with 100, 200, and 400 mg/kg seed extract, respectively. Tail vein blood glucose of each mouse was measured at 0 (before treatment) and at 1, 2, 4, and 6 hours post-treatment.[@CIT0036]

Glucose Tolerance Test (OGTT) {#S0002-S2010}
-----------------------------

To evaluate acute glucose lowering potential hydromethanolic seed extract of *D. stramonium*, OGTT was employed on 16 hour fasted mice.[@CIT0024],[@CIT0038] Normoglycemic overnight fasted mice were randomly assigned into five groups (n=6). Group I and II (negative and positive control) were treated with 10 mL/kg distilled water and 5 mg/kg glibenclamide, respectively; Group III, IV, and V were treated with 80% methanolic seed extract at the dose of 100, 200, and 400 mg/kg, respectively. After 30 minutes, 40% glucose solution was administered at the dose of 2 g/kg to each mouse.[@CIT0034],[@CIT0039] Tail vein blood glucose of each mouse was measured before glucose loading and then at 30, 60, and 120 minutes post-glucose loading.[@CIT0037],[@CIT0040],[@CIT0041]

The Effect of Hydromethanolic Seed Extract on Blood Glucose Level and Body Weight in STZ-Induced Diabetic Mice {#S0002-S2011}
--------------------------------------------------------------------------------------------------------------

Overnight (16 hour) fasted diabetic mice were randomly grouped into six groups (n=6). Group I was treated with 10 mL/kg distilled water; Group II (diabetic positive control) was treated with 5 mg/kg glibenclamide; Groups III, IV, and IV (diabetic test groups) were treated with 80% methanolic seed extract at the dose of 100, 200, and 400 mg/kg every day for 2 weeks, respectively. Fasting blood glucose level and body weight of each mouse was measured on day 1 (After 3-day STZ injection). On weeks 1 and 2, overnight fasting mice were given vehicle, glibenclamide and seed extract in respect to their grouping and then, after 2 hours, blood glucose level and body weight of the mice were measured.[@CIT0013],[@CIT0039]

Statistical Analysis {#S0002-S2012}
--------------------

The data was expressed as mean±standard error of the mean. Means of all parameters among groups and within a group were compared using one-way ANOVA followed by Tuckey's post-hoc multiple comparison test. *P*-values\<0.05 were considered statistically significant and SPSS Version 23 Software was used for analysis.

Results {#S0003}
=======

Acute Oral Toxicity Test {#S0003-S2001}
------------------------

Sign of toxicity and mortality associated with 2,000 mg/kg loading hydromethanol seed extract of *D. stramonium* not recorded in female mice within 2 weeks observation. Therefore, LD50 of hydromethanolic seed extract is \>2,000 mg/kg.

Phytochemical Screening of Hydromethanolic Seed Extract of *D. stramonium* {#S0003-S2002}
--------------------------------------------------------------------------

Qualitative preliminary phytochemical study showed that hydromethanolic seed extract contained secondary metabolites ([Table 1](#T0001){ref-type="table"}).Table 1Phytochemical Screening of 80% Methanolic Seed Extract of *D. stramonium*PhytoconstituentsResultFlavonoids+Phenols+Tannins+Saponins+Alkaloids+Terpenoids+Glycosides+Steroids+Anthraquinones--[^1]

Antioxidant Activity of the Seed Extract of *D. stramonium* {#S0003-S2003}
-----------------------------------------------------------

The finding of the study showed that free radical-scavenging activity of the seed extract was concentration dependent and comparable to ascorbic acid. IC50 of the seed extract and ascorbic acid in the assay was found to be 11.95 and 5.07 mg/mL, respectively ([Table 2](#T0002){ref-type="table"}).Table 2Percentage of Free Radical-Scavenging Activity of the Seed Extract of *D. stramonium*Concentration\
(mg/mL)% of DPPH InhibitionIC50AASEAASE528.22±0.216.67±0.711045.66±0.4214.14±0.534.9711.952066.81±0.4221.01±0.414080.26±0.4528.01±0.318092.53±0.5440.54±0.27[^2][^3]

Effect of Hydromethanolic Seed Extract of *D. stramonium* in Normoglycemic Mice {#S0003-S2004}
-------------------------------------------------------------------------------

All doses of hydromethanolic seed extract of *D. stramonium* were devoid of a significant hypoglycemic effect at all time points in normoglycemic mice compared to negative control. The standard drug (5 mg/kg glibenclamide) showed a significant (*P*\<0.001) hypoglycemic effect at 2, 4, and 6 hours with respect to negative control ([Table 3](#T0003){ref-type="table"}).Table 3Effect of Hydromethanolic Seed Extract of *D. stramonium* in Normoglycemic MiceFasting BGL (mg/dL)Groups0 hour1 hour2 hours4 hours6 hours10 mL/kg NC90.46±0.3188.29±0.7580.52±0.6875.82±1.7175.06±2.035 mg/kg GB89.28±1.0272.82±0.9166.79±1.06^a,\*\*,b,\*^60.39±2.29^a,\*\*,b,\*^56.45±2.09^a,\*\*,b,\*^100 mg/kg SE90.53±1.7587.21±0.4279.58±0.74^c,\*^74.83±1.73^c,\*^74.09±0.39^c,\*^200 mg/kg SE89.53±0.4586.45±1.9077.88±1.3073.97±1.1773.56±2.03400 mg/kg SE90.06±1.6485.51±0.4677.62±1.2972.88±1.2572.11±2.69[^4][^5]

Effect of Hydromethanolic Seed Extract of *D. stramonium* on Blood Glucose Level in Oral Glucose-Loaded Mice {#S0003-S2005}
------------------------------------------------------------------------------------------------------------

There was no significant variation in fasting blood glucose level of the mice before oral glucose administration and at 30 minutes in all groups ([Figure 2](#F0002){ref-type="fig"}). Maximum blood glucose level was measured after 30 minutes of glucose administration. Glucose reduction of the seed extract was significant (*P*\<0.05 at 100, *P*\<0.01 at 200 and 400 mg/kg) after 60 and 120 minutes glucose administration compared to the negative control. Glucose reduction of 100 mg/kg dose was significantly (*P*\<0.05) lower than 5 mg/kg glibenclamide (*P*\<0.001).Figure 2Effect of 80% methanolic seed extract of *D. stramonium* on blood glucose level of oral glucose-loaded mice.

Antihyperglycemic Effects of Hydromethanolic Seed Extract of *D. stramonium* in Diabetic Mice {#S0003-S2006}
---------------------------------------------------------------------------------------------

After induction of diabetes, the blood glucose level of daily-treated diabetic mice was measured every week. The seed extract at the doses of 100, 200, and 400 mg/kg significantly (*P*\<0.01) reduced the glucose level at week 1 and 2 compared to the diabetic control group ([Table 4](#T0004){ref-type="table"}). Glucose reduction of glibenclamide was significant (*P*\<0.001) at week 1 and 2 compared to the diabetic control group. There was no significant BGL variation among seed extract and standard drug in the STZ-induced model.Table 4Antihyperglycemic Effects of 80% Methanolic Seed Extract of *D. stramonium* in Diabetic MiceGroupFasting BGL (mg/dL)Day 0Day 7Day 1410 mL/kg NC254.62±1.05266.00±1.73268.94±0.495 mg/kg GB255.46±0.34243.22±0.42^a,\*\*^240.18±1.63^a,\*\*^100 mg/kg SE256.06±1.27255.06±0.57^a,\*^250.22±0.29^a,\*^200 mg/kg SE255.44±0.88249.17±1.06^a,\*^248.55±1.06^a,\*^400 mg/kg SE255.89±0.92246.45±0.51^a,\*^247.17±0.25^a,\*^[^6][^7]

Effect of Hydromethanolic Seed Extract of *D. stramonium* on Body Weight of Diabetic Mice {#S0003-S2007}
-----------------------------------------------------------------------------------------

The seed extract at the doses of 200 and 400 mg/kg significantly (*P*\<0.05) increased the BW of diabetic mice at week 1 and 2 compared to diabetic control ([Table 5](#T0005){ref-type="table"}). The effect of the 100 mg/kg dose was delayed and significantly (*P*\<0.05) improved BW at week 2 compared to the negative control group. In addition, glibenclamide significantly (*P*\<0.01) improved the body weight of diabetic mice at week 1 and 2 with respect to negative control group.Table 5Effect of 80% Methanolic Seed Extract of *D. stramonium* on Body Weight of Diabetic MiceGroupsBody Weight (g)Day 0Day 7Day 1410 mL/kg NC22.89±0.6922.84±0.5123.08±0.645 mg/kg GB23.43±0.3327.59±0.31^a,\*\*^28.26±0.46^a,\*\*^100 mg/kg SE22.59±0.5524.59±0.64^a,\*^25.48±0.49^a,\*^200 mg/kg SE23.87±0.2326.34±0.53^a,\*^25.91±0.61^a,\*^400 mg/kg SE24.27±0.6327.21±0.39^a,\*^26.72±0.34^a,\*^[^8][^9]

Discussion {#S0004}
==========

Blood glucose reduction potential of hydromethanolic seed extract of *D. stramonium* was evaluated in normoglycemic, glucose-loaded, and Streptozocin-induced diabetic mice. The normoglycemic model was used to determine the hypoglycemic effect of the seed extract and acute postprandial glucose reduction of the plant was assessed in the oral glucose tolerance test.[@CIT0013],[@CIT0036],[@CIT0042] Cumulative blood glucose reduction ability of the plant was evaluated in every day-treated Streptozocin-induced diabetic mice.[@CIT0038] Hydromethanol (80% methanol) was selected as the solvent of the extraction since a wide variety of polar and moderately polar phytomolecules were extracted in hydromethanol.[@CIT0024],[@CIT0036],[@CIT0043]

Diphenyl-1-picrylhydrazine (DPPH) is a stable free radical widely employed to determine the antioxidant capacity of natural products.[@CIT0044] In the present finding, hydromethanolic seed extract showed concentration dependent antioxidant activity. IC50 of the seed extract was found to be 11.95 mg/mL, which is comparable with the IC50 of ascorbic acid (5.07 mg/mL). The finding is in line with the concentration dependent antioxidant activity of root extract of the plant.[@CIT0024] Plant derived supplement prevents the devastating effect of oxidative stress (ROS) in chronic diseases like diabetes mellitu[@CIT0045] and the study plant might offer health benefits through it\'s antioxidant property.

Normoglycemic models offer a clue to predict the mechanism of action of natural remedies and detect hyperglycemic agents.[@CIT0032],[@CIT0036] In the current study, all doses of hydromethanolic seed extract did not show significant hypoglycemia at all time points compared to the negative control group. Blood glucose reduction of standard drug (5 mg/kg glibenclamide) was significant (*P*\<0.01) at 2, 4, and 6 hours in normoglycemic mice. Therefore, the mechanism of action in glucose lowering activity of hydromethanolic seed extract of *D. stramonium* and glibenclamide might not be the same. Similar to this finding, hydromethanolic seed extract of *Calpurnia aurea* and root extract of the plant devoid significant hypoglycemic activity in normoglycemic mice.[@CIT0024],[@CIT0046]

Glucose tolerance test (OGTT) was employed in the current study to determine acute blood glucose reduction potential of hydromethanolic seed extract of *D. stramonium*. The result showed that the glucose level was significantly (*P*\<0.05 at 100 mg/kg, *P*\<0.01 at 200 mg/kg and 400mg/kg) reduced after 60 and 120 minutes oral glucose loaded compared to the negative control group. Glucose reduction effect was found to be dose dependent in the glucose tolerance test. Blood glucose reduction of 100 mg/kg dose was significantly (*P*\<0.05) lower than 5 mg/kg glibenclamide (*P*\<0.001, after 60 and 120 minutes). Similar to this finding, hydromethanolic seed extract of *Calpurnia aurea* and root extract of the plant revealed a significant glucose reduction in oral glucose-loaded mice.[@CIT0024],[@CIT0046]

Streptozocin is a widely used diabetogenic agent to induce experimental diabetes in rodent models. A single dose of Streptozocin at 150 mg/kg induced type I diabetes through destroying pancreas β cells by DNA methylation and free radical generation.[@CIT0033],[@CIT0047],[@CIT0048] In the STZ-induced diabetic model, the blood glucose level of daily-treated diabetic mice was measured every week. The result of the study showed that blood glucose level was significantly (*P*\<0.01) changed at the dose of 100, 200, and 400 mg/kg hydromethanolic seed extract on week 1 and 2 compared to negative control. This showed that the plant endowed antidiabetic activity and in line with hydromethanolic seed extract of *Calpurnia aurea* and root extract of the plant,[@CIT0024],[@CIT0046] in a streptozotocin-induced diabetic model. In another study, the seed extract of *Datura metel* in the genus *Datura* showed significant blood glucose lowering activity.[@CIT0049]

At the same time, there was significant improvement of body weight in seed extract and standard drug-treated groups in respect to negative control in STZ-induced diabetic mice. Body weight of the mice treated with all doses of hydromethanolic seed extract of *D. stramonium* significantly improved at week 1 and 2. This implies that hydromethanolic seed extract of the study plant prevention of hyperglycemia induced muscle wastage.

Preliminary phytochemical analysis of hydromethanolic seed extract of *D. stramonium* showed the present of secondary metabolites (flavonoids, glycosides, alkaloids, terpenoids, and others) which revealed antihyperglycemic and antioxidant activities in different plants extracts through various mechanisms of action.[@CIT0013],[@CIT0045] Alkaloids, flavonoids, terpenoids, phenols, and glycosides have been presented in *Datura metel*, *Moringa stenopetala*, *Calpurnia aurea,* and other plant extracts,[@CIT0013],[@CIT0024],[@CIT0042],[@CIT0045] that endowed potential antidiabetic and antioxidant activities. Therefore, the antihyperglycemic activity of hydromethanolic seed extract of *D. stramonium* was possibly due to a single or synergetic action of these secondary metabolites.

Conclusion {#S0005}
==========

The finding of the study showed that hydromethanolic seed extract of *Datura stramonium* endowed significant antihyperglycemic and antioxidant activities. Further investigation will require for bioassay guided fractionation, isolation, and characterization of active compound(s) that possess antidiabetic activity of the plant.
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[^1]: **Notes:** +, present; --, absent.

[^2]: **Note:** Values of % inhibition of DPPH free radical is described as mean±standard error of the mean.

[^3]: **Abbreviations:** AA, ascorbic acid; DPPH, 2.2-diphenyl-1-picrylhydrazine; IC, inhibitory concentration; SE, seed extract.

[^4]: **Notes:** Each data describes as mean±standard error of the mean, n=6; ^a^compared to negative control; ^b^to 100 mg/kg; ^c^to 5 mg/kg GB; ^\*^*P*\<0.05; ^\*\*^*P*\<0.001.

[^5]: **Abbreviations:** BGL, blood glucose level; GB, glibenclamide; NC, negative control; SE, seed extract.

[^6]: **Notes:** Each data described as mean±standard error of the mean, n=6; ^a^compared to negative control; ^\*^*P*\<0.01; ^\*\*^*P*\<0.001.

[^7]: **Abbreviations:** BGL, blood glucose level; GB, glibenclamide; NC, negative control; SE, seed extract.

[^8]: **Notes:** Each data described as mean±standard error of the mean, n=6; ^a^compared to negative control; ^\*^*P*\<0.05; ^\*\*^*P*\<0.01.

[^9]: **Abbreviations:** GB, glibenclamide; NC, negative control; SE, seed extract.
